Australian Clinical Labs raises final dividend from $0.07 to $0.09 per share, yielding 2.87%.
Australian Clinical Labs Limited (ASX:ACL) has raised its final dividend from $0.07 to $0.09 per share, with payment set for September 26th to shareholders on record as of that date. The increase results in a dividend yield of 2.87%, with an ex-dividend date of September 3rd. The company provides a variety of pathology services, including routine tests and molecular genetics testing.
September 02, 2024
4 Articles